Table 3.
Healthy (n = 12) | Mastitis Sample (n = 1) | Non-Mammary Surgery Sample (n = 1) | ||
---|---|---|---|---|
Median (Range) | Mastitis Breast | Adjacent Breast | ||
CD45–Granzyme A (%) | ||||
All single cells | 0.2 (0.0–14.9) | 0.2 | 0.4 | |
Population 1 | 1.0 (0.3–32.6) | 10.9 | 5.4 | |
Population 2 | 0.2 (0.0–50.0) | 3.5 | 1.3 | |
Population 3 | 0.2 (0.0–0.4) | 0.2 | 0 | |
CD45–Granzyme B (%) | ||||
All single cells | 0.7 (0.0–5.5) | 0.5 | 0.4 | 4.4 |
Population 1 | 5.2 (0.0–26.8) | 27 | 17.2 | 33.4 |
Population 2 | 0.3 (0.0–13.9) | 0.3 | 4.2 | 20.3 |
Population 3 | 0.0 (0.0–0.3) | 0 | 0.3 | 1.4 |
CD45–Granulysin (%) | ||||
All single cells | 0.7 (0.0–10.4) | 0.3 | 4.1 | |
Population 1 | 3.2 (0.8–21.1) | 4.4 | 12.9 | |
Population 2 | 3.6 (0.0–13.4) | 5.8 | 34 | |
Population 3 | 13.6 (0.2–27.1) | 0.1 | 0.9 | |
CD45–Perforin (%) | ||||
All single cells | 0.9 (0.6–8.3) | 0.8 | 0.9 | 23.7 |
Population 1 | 11.0 (0.1–35.2) | 34.1 | 8.2 | 27.7 |
Population 2 | 2.1 (0.1–26.8) | 3.9 | 10.6 | 48.2 |
Population 3 | 0.7 (0.1–1.8) | 0.7 | 0.1 | 4.8 |
EPCAM–Granzyme A (%) | ||||
All single cells | 0.0 (0.0–0.2) | 0.1 | 0 | |
Population 1 | 0.1 (0.0–35.2) | 0.1 | 0.1 | |
Population 2 | 0.4 (0.0–1.5) | 0.6 | 0 | |
Population 3 | 1.0 (0.2–1.8) | 0.2 | 0 | |
PCAM–Granzyme B (%) | ||||
All single cells | 0.2 (0.1–1.0) | 1.3 | 0 | 1.5 |
Population 1 | 0.5 (0.3–3.5) | 2.2 | 0.6 | 0.9 |
Population 2 | 1.4 (0.0–3.0) | 0.3 | 0.5 | 6.1 |
Population 3 | 1.3 (0.2–2.3) | 0 | 0.2 | 1.1 |
EPCAM–Granulysin (%) | ||||
All single cells | 0.2 (0.0–2.1) | 0.1 | 2.4 | |
Population 1 | 1.5 (0.2–3.1) | 1.8 | 1 | |
Population 2 | 0.6 (0.1–1.4) | 1.4 | 7.9 | |
Population 3 | 2.6 (0.2–5.0) | 0.1 | 1.9 | |
EPCAM–Perforin (%) | ||||
All single cells | 0.2 (0.0–5.5) | 0.2 | 0.1 | 5.2 |
Population 1 | 3.3 (1.1–9.5) | 2.1 | 0.5 | 2.2 |
Population 2 | 1.7 (0.3–8.4) | 0.7 | 1.1 | 7.4 |
Population 3 | 0.4 (0.3–0.4) | 0.3 | 0 | 1.8 |